Skip to content

Cancers & treatments

News & evidence

Living with cancer

Learn & contribute

Loading

A public, cited, editable map of oncology: technologies, targets, products, companies, institutions, pathways, trials, pairings, roadmaps, and ideas. One page per object, with a plain-language TL;DR on every page.

Work in progress. Every fact on this site is being built and checked in the open and may be incomplete, out of date, or wrong. You must do your own research and verify anything here at its primary source before relying on it. Nothing on this site is medical advice; decisions belong with you and your clinicians.

OnCo is an information resource, not medical advice. Nothing here replaces a conversation with a qualified clinician. Never delay care because of something you read here; in an emergency, call your local emergency services. Terms of use

Browse by cancer
Tags
Search
Connections
For me
Navigator
Biomarker matrix
Calculators
Interactions
Decision aids
Checkpoint side effects
Tumour board
Compare
Counts by category
Rankings
Timeline
Year by year
Query builder
Graph explorer
Saved
Body map

Cancers & treatments

News & evidence

Institutions & people

Institutions
Universities
Trial leadership
People
Heroes and heroines
Companies
Startups
Requests for startups
Investors
Company scorecards
Trial sponsors
Manufacturing map
Countries
United States deep dive
India deep dive
China deep dive
Germany deep dive
Israel deep dive
United Kingdom deep dive
Cases by country
Funding flows

Living with cancer

For me
The first 60 days
Appointment prep pack
Side effects
Symptom to test
Report reader
Survivorship planner
Second opinion
Financial help
Free in oncology
Paying for care in the US
NHS coverage
Paying for care in India
Coverage rankings
Cutting cancer care costs
Diet, exercise and lifestyle
Supportive care
Recovery and rejuvenation
Complementary and supportive approaches
Hair loss and regrowth
What comes back after treatment
Heroes and heroines

Learn & contribute

Reading paths
About & methodology
Roadmap
Gaps to fill
Coverage of the field
Review queue
Reviewer roster
Contributors
Idea votes
Teaching packs
Weekly issue
Suggest an edit
Answer quality
Data dictionary
Build on OnCo
Open API
Open data
Open tools
Open source in oncology
The software of oncology
GitHub

© 2026 OnCo. Code MIT. The data are free for individual and educational use with the attribution “Data from OnCo (onco.cc)”, under CC BY-NC 4.0. Commercial use must contact us to pay for the data. Commercial licences. Made with heart and soul by Jude Gomila .

About and methodology Corrections Open API Tags Terms of use Privacy policy GitHub

Loading

Home
Key papers
Gallbladder cancer mortality in Chile: has the government program targeting young gallstone patients had an impact?

key papersKey paper

Gallbladder cancer mortality in Chile: has the government program targeting young gallstone patients had an impact?

An epidemiological analysis, with US National Cancer Institute authors, of whether Chile's preventive gallbladder surgery programme has cut deaths from gallbladder cancer.

Overview Key papers1 Connected7

Overview

American Journal of Epidemiology analysis by Chilean and US National Cancer Institute investigators of gallbladder cancer mortality in Chile in relation to the GES programme targeting gallstone patients aged 35 to 49. Europe PMC indexes no abstract for this article, so OnCo carries no figures from it; the two Revista Medica de Chile evaluations linked from this record supply the numbers OnCo quotes.

Observational studyHas not changed practice yet4 citations

Authors

Cid V, Vargas C, Delgado I, et al.

Published

American Journal of Epidemiology, 2024

Full text

doi:10.1093/aje/kwae027 PubMed 38576158

Findings

No abstract is indexed on Europe PMC; no figures are transcribed.

What it means

The most rigorous evaluation of the Chilean programme available; read alongside Mardones and Frenz (2019) and Samaniego and colleagues (2024).

Caveats

No abstract indexed; conclusions not transcribed here.

Key papers

observationalRevista Medica de Chile 20240 citations

Gallbladder Cancer: Is It Time to Modify the Explicit Health Guarantees (GES) Program?

The only national prophylactic cholecystectomy programme in the world has run for nearly twenty years without a design that can show whether it works. Targeting by region and risk, and building in an evaluation, is the obvious next step.

Connected

Similar pages

Key paper
Geographic and genetic diversity in gallbladder cancer mutation profiles: insights from a worldwide exome analysis
Shares Redesign Chile's prophylactic cholecystectomy programme around risk, and evaluate it properly, Gallbladder cancer roadmap: from a chance finding at gallstone surgery to a disease with its own trials, Gallbladder cancer and the tag gallbladder-evidence.
Key paper
Salmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis
Shares Prophylactic (preventive) cholecystectomy, Gallbladder cancer roadmap: from a chance finding at gallstone surgery to a disease with its own trials, National Cancer Institute (NIH), Gallbladder cancer and the tag gallbladder-evidence.
Key paper
Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer
Shares Prophylactic (preventive) cholecystectomy, Gallbladder cancer roadmap: from a chance finding at gallstone surgery to a disease with its own trials, Gallbladder cancer and the tag gallbladder-evidence.
Idea
Cholecystectomy or ultrasound surveillance for chronic typhoid carriers in endemic regions
Shares Prophylactic (preventive) cholecystectomy, Gallbladder cancer roadmap: from a chance finding at gallstone surgery to a disease with its own trials, Gallbladder cancer and the tag gallbladder-evidence.
Key paper
Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition
Shares Prophylactic (preventive) cholecystectomy, Gallbladder cancer and the tag gallbladder-evidence.
Key paper
Gallbladder cancer
Shares Gallbladder cancer roadmap: from a chance finding at gallstone surgery to a disease with its own trials, National Cancer Institute (NIH), Gallbladder cancer and the tag gallbladder-evidence.
Key paper
Carcinoma of the gallbladder: staging, treatment, and prognosis
Shares Gallbladder cancer roadmap: from a chance finding at gallstone surgery to a disease with its own trials, Gallbladder cancer and the tag gallbladder-evidence.
Key paper
Systematic review of management of incidental gallbladder cancer after cholecystectomy
Shares Gallbladder cancer roadmap: from a chance finding at gallstone surgery to a disease with its own trials, Gallbladder cancer and the tag gallbladder-evidence.

cancers

Gallbladder cancer

institutions

National Cancer Institute (NIH)

terms

Prophylactic (preventive) cholecystectomy

roadmaps

Gallbladder cancer roadmap: from a chance finding at gallstone surgery to a disease with its own trials

ideas

Redesign Chile's prophylactic cholecystectomy programme around risk, and evaluate it properly

key papers

Changes in gallbladder cancer mortality and hospital discharges due to preventive cholecystectomy in Chile Gallbladder Cancer: Is It Time to Modify the Explicit Health Guarantees (GES) Program?

ProvenanceLast edited 2026-09-24 · Jude Gomila · Gallbladder cancer evidence · diff · file

Sources & links

Am J Epidemiol 2024
PubMed

gallbladder-evidence

Data

Follow this page

Wrong or missing?

Propose a change with a source. Organisations can update their own records. Every suggestion is reviewed, safety-checked and validated before it goes live; nothing is edited directly.

Suggest an editDiscuss start a thread

Out of date?
How review works

Cancers

Gallbladder cancer

Institutions

National Cancer Institute (NIH)

Terms

Prophylactic (preventive) cholecystectomy

Related

Gallbladder Cancer: Is It Time to Modify the Explicit Health Guarantees (GES) Program?
Changes in gallbladder cancer mortality and hospital discharges due to preventive cholecystectomy in Chile

Not yet reviewedNeeds expert (scientific) review. Review this page or see the review queue and roster.

Model panel commentary is coming to this page: machine commentary, not clinical review.

Machine-readable versions of Gallbladder cancer mortality in Chile: has the government program targeting young gallstone patients had an impact?

JSON record with neighbours
Markdown context for language models
RDF Turtle for this record (its triples, relations and owl:sameAs; the IRI of this record is https://onco.cc/key-papers/paper-cid-chile-programme-gallbladder-cancer-mortality-am-j-epidemiol-2024/)
All key papers as JSON
RDF N-Triples for the whole corpus
Search index: id, kind, name, TL;DR and route for every record
OpenAPI 3.1 description
API root and meta.json
llms.txt

MCP server: npx -y onco-mcp, tools search, get_entity, list_kind, ask, context, compare. This record is get_entity or context with id paper-cid-chile-programme-gallbladder-cancer-mortality-am-j-epidemiol-2024.

WebMCP tools registered on this page: onco_search, onco_get_entity.